Pioglitazone inhibits high glucose-induced synthesis of extracellular matrix by NF-κB and AP-1 pathways in rat peritoneal mesothelial cells.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Molecular Medicine Reports

• Publication date

  2013-04-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.3892/mmr.2013.1309PMID 23404530
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of NF-κB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells

  2011cited by this paper
• Inhibition of reactive oxygen species/extracellular signal-regulated kinases pathway by pioglitazone attenuates advanced glycation end products-induced proliferation of vascular smooth muscle cells in rats.

  2011cited by this paper
• Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.

  2008cited by this paper
• Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model.

  2008cited by this paper
• Glucose‐Based PD Solution, But Not Icodextrin‐Based PD Solution, Induces Plasminogen Activator Inhibitor‐1 and Tissue‐Type Plasminogen Activator in Human Peritoneal Mesothelial Cells via ERK1/2

  2007cited by this paper
• Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.

  2007cited by this paper
• Peroxisome Proliferator-Activated Receptor-Gamma Is Expressed by Rat Peritoneal Mesothelial Cells: Its Potential Role in Peritoneal Cavity Local Defense

  2007cited by this paper
• Peroxisome Proliferator-Activated Receptor-γ Agonists Diminish Peritoneal Functional and Morphological Changes Induced by Bioincompatible Peritoneal Dialysis Solution

  2006cited by this paper
• Peroxisome-proliferator-activated receptor-gamma agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells.

  2006cited by this paper
• Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone.

  2006cited by this paper
• Troglitazone inhibits synthesis of transforming growth factor‐β1 and reduces matrix production in human peritoneal mesothelial cells

  2006cited by this paper
• Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats.

  2005cited by this paper
• PPARgamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose.

  2005cited by this paper
• Effects of Glucose and Plasminogen Activator Inhibitor‐1 on Collagen Metabolism in the Peritoneum

  2005cited by this paper
• Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic responses.

  2004cited by this paper
• Emodin ameliorates glucose-induced matrix synthesis in human peritoneal mesothelial cells.

  2003cited by this paper
• High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-κB and AP-1

  2003cited by this paper
• High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1.

  2003cited by this paper
• A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis.

  2003cited by this paper
• Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications.

  2003cited by this paper
• Morphological and functional changes in the dialysed peritoneal cavity: impact of more biocompatible solutions.

  2002cited by this paper
• Constitutive Activation of Peroxisome Proliferator-activated Receptor-γ Suppresses Pro-inflammatory Adhesion Molecules in Human Vascular Endothelial Cells*

  2002cited by this paper
• Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.

  2002cited by this paper
• Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation.

  2001cited by this paper
• AP-1 in cell proliferation and survival

  2001cited by this paper
• Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity

  2001cited by this paper
• Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells

  2001cited by this paper
• New insights into the role of nuclear factor-kappaB in cell growth regulation.

  2001cited by this paper
• Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.

  2001cited by this paper
• New Insights into the Role of Nuclear Factor-κB in Cell Growth Regulation

  2001cited by this paper
• Effect of High Glucose on Peritoneal Mesothelial Cell Biology

  2000cited by this paper
• Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries.

  2000cited by this paper
• Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats.

  2000cited by this paper
• Thiazolidinedione Compounds Ameliorate Glomerular Dysfunction Independent of Their Insulin-Sensitizing Action in Diabetic Rats

  2000cited by this paper
• The role of oxidative stress and NF‐κB activation in late diabetic complications

  1999cited by this paper
• What really happens to people on long-term peritoneal dialysis?

  1998cited by this paper
• Altered Activities of Transcription Factors and Their Related Gene Expression in Cardiac Tissues of Diabetic Rats

  1998cited by this paper
• Peritoneal Dialysis Solution Biocompatibility: Inhibitory Mechanisms and Recent Studies with Bicarbonate-Buffered Solutions

  1997cited by this paper
• Ultrastructure and pathology of the peritoneum in peritoneal dialysis

  1994cited by this paper
• Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB

  1993cited by this paper
• Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B.

  1993cited by this paper
• Peritoneal Ultrastructure and Changes with Continuous Ambulatory Peritoneal Dialysis

  1993cited by this paper
• Isolation and Propagation in Vitro of Peritoneal Mesothelial Cells

  1989cited by this paper

• The Role of NF-κB in Peritoneal Fibrosis and Adhesion in Humans and Animals: A Systematic Review

  2026cites this paper
• Peritoneal Dialysis -Associated Fibrosis: Emerging Mechanisms and Therapeutic Opportunities

  2025cites this paper
• Sterile inflammation of peritoneal membrane caused by peritoneal dialysis: focus on the communication between immune cells and peritoneal stroma

  2024cites this paper
• FUT3 facilitates glucose metabolism of lung adenocarcinoma via activation of NF-κB pathway

  2023cites this paper
• Comparison of changes in adipokine and inflammatory cytokine levels in patients with newly diagnosed type 2 diabetes treated with exenatide, insulin, or pioglitazone: A post-hoc study of the CONFIDENCE trial

  2023cites this paper
• Elucidating the Novel Mechanism of Ligustrazine in Preventing Postoperative Peritoneal Adhesion Formation

  2022cites this paper
• Transcriptome analysis reveals hepatotoxicity in zebrafish 1 induced by cyhalofop-butyl 2

  2022cites this paper
• Transcriptome analysis reveals hepatotoxicity in zebra sh induced by cyhalofop-butyl

  2022cites this paper
• Transcriptome analysis reveals hepatotoxicity in zebrafish induced by cyhalofop-butyl

  2022cites this paper
• PPARγ alleviates peritoneal fibrosis progression along with promoting GLUT1 expression and suppressing peritoneal mesothelial cell proliferation

  2022cites this paper
• Dietary lycopene attenuates cigarette smoke-promoted nonalcoholic steatohepatitis by preventing suppression of antioxidant enzymes in ferrets.

  2021cites this paper
• Hepatoprotective effect of Forsythiaside A against acetaminophen-induced liver injury in zebrafish: coupling network pharmacology with biochemical pharmacology.

  2021cites this paper
• Effect of astragaloside IV and the role of nuclear receptor RXRα in human peritoneal mesothelial cells in high glucose-based peritoneal dialysis fluids

  2019cites this paper
• Delayed administration of suramin attenuates peritoneal fibrosis in rats

  2019cites this paper
• Arctigenin alleviates TGF-β1-induced epithelial-mesenchymal transition and PAI-1 expression via AMPK/NF-κB pathway in peritoneal mesothelial cells.

  2019cites this paper
• Pleiotrophin, a target of miR‐384, promotes proliferation, metastasis and lipogenesis in HBV‐related hepatocellular carcinoma

  2017cites this paper
• Transforming growth factor-β 1 induces fibrosis in rat meningeal mesothelial cells via the p 38 signaling pathway

  2016cites this paper
• Transforming growth factor-β1 induces fibrosis in rat meningeal mesothelial cells via the p38 signaling pathway.

  2016cites this paper
• Inhibition of NF-kappaB with Dehydroxymethylepoxyquinomicin modifies the function of human peritoneal mesothelial cells.

  2016cites this paper
• Preserving the peritoneal membrane in long‐term peritoneal dialysis patients

  2015cites this paper
• Telmisartan attenuates peritoneal fibrosis via peroxisome proliferator‐activated receptor‐γ activation in rats

  2015cites this paper
• Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist inhibits collagen synthesis in human hypertrophic scar fibroblasts by targeting Smad3 via miR-145.

  2015cites this paper